Pages that link to "Q35186401"

The following pages link to Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening. (Q35186401):

Displaying 35 items.

• Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis (Q26778122) (← links)
• Etiology and Prevention of Gastric Cancer (Q28072819) (← links)
• Diagnosis and management of high risk group for gastric cancer (Q28084323) (← links)
• Serum trefoil factor 3 is a promising non-invasive biomarker for gastric cancer screening: a monocentric cohort study in China (Q33574985) (← links)
• Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer (Q33885064) (← links)
• Serum TFF3 may be a pharamcodynamic marker of responses to chemotherapy in gastrointestinal cancers (Q33905866) (← links)
• Trefoil factor 3 as a novel biomarker to distinguish between adenocarcinoma and squamous cell carcinoma (Q36152945) (← links)
• Reduced expression of TFF1 and increased expression of TFF3 in gastric cancer: correlation with clinicopathological parameters and prognosis (Q36540105) (← links)
• Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer (Q36642525) (← links)
• CPA4 is a Novel Diagnostic and Prognostic Marker for Human Non-Small-Cell Lung Cancer (Q37067977) (← links)
• Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis (Q37572532) (← links)
• Diagnostic value evaluation of trefoil factors family 3 for the early detection of colorectal cancer (Q37730876) (← links)
• Quantitative measurements of trefoil factor family peptides: possibilities and pitfalls (Q38079874) (← links)
• Implementation of gastric cancer screening - the global experience (Q38273499) (← links)
• Trefoil factor family 2 expression inhibits gastric cancer cell growth and invasion in vitro via interactions with the transcription factor Sp3. (Q38743770) (← links)
• Atrophic gastritis and enlarged gastric folds diagnosed by double-contrast upper gastrointestinal barium X-ray radiography are useful to predict future gastric cancer development based on the 3-year prospective observation. (Q38951487) (← links)
• Trefoil Factor Peptides and Gastrointestinal Function. (Q39043302) (← links)
• TFF2 deficiency exacerbates weight loss and alters immune cell and cytokine profiles in DSS colitis, and this cannot be rescued by wild-type bone marrow (Q39111716) (← links)
• Comparison of serum trefoil factor 3 with the pepsinogen test for the screening of diffuse-type gastric cancer. (Q39787119) (← links)
• Serum Level of Trefoil Factor 2 can Predict the Extent of Gastric Spasmolytic Polypeptide-Expressing Metaplasia in the H. pylori-Infected Gastric Cancer Relatives (Q40661433) (← links)
• Effect of Rebamipide on the Premalignant Progression of Chronic Gastritis: A Randomized Controlled Study (Q41000823) (← links)
• Serum Trefoil Factor 3 as a Protein Biomarker for the Diagnosis of Colorectal Cancer (Q42046586) (← links)
• Influence of Helicobacter pylori status and eradication on the serum levels of trefoil factors and pepsinogen test: serum trefoil factor 3 is a stable biomarker (Q44182319) (← links)
• Trefoil factor 3 contributes to the malignancy of glioma via regulating HIF-1α. (Q44854266) (← links)
• Plasma expression of the intestinal metaplasia markers CDH17 and TFF3 in patients with gastric cancer (Q51029933) (← links)
• How Close Are we to Finding Noninvasive Markers for Upper GI Tract Cancer? (Q51671468) (← links)
• Determination of urinary 5-hydroxyindoleacetic acid as a metabolomics in gastric cancer. (Q53587011) (← links)
• Urine Trefoil Factors as Prognostic Biomarkers in Chronic Kidney Disease. (Q55406066) (← links)
• Screening Biomarker as an Alternative to Endoscopy for the Detection of Early Gastric Cancer: The Combination of Serum Trefoil Factor Family 3 and Pepsinogen. (Q55413302) (← links)
• miR-632 promotes gastric cancer progression by accelerating angiogenesis in a TFF1-dependent manner (Q60918409) (← links)
• Prediction of Chronic Atrophic Gastritis and Gastric Neoplasms by Serum Pepsinogen Assay: A Systematic Review and Meta-Analysis of Diagnostic Test Accuracy. (Q64900104) (← links)
• Renal expression of trefoil factor 3 mRNA in association with tubulointerstitial fibrosis in IgA nephropathy (Q89484845) (← links)
• Prognostic Value of Trefoil Factor 3 Expression in Patients with Gastric Cancer (Q90434164) (← links)
• Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study (Q92998444) (← links)
• Novel urinary protein biomarker panel for early diagnosis of gastric cancer (Q99551351) (← links)